Skip to main content
Equibles

Schonfeld Strategic Advisors LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1665241 NEW YORK, NY
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,529,909
+$1,270,323 QoQ
Shares Held
416,869
+393.0% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 344 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. RXRX ranks #65 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 697,586 $66,096,273
2 AGIO
Agios Pharmaceuticals, Inc.
 520,083 $19,300,280
3 JAZZ
Jazz Pharmaceuticals plc
 77,272 $18,620,233
4 VRDN
Viridian Therapeutics, Inc.\DE
 793,508 $14,576,741
5 MBX
MBX Biosciences, Inc.
 248,670 $13,726,584
6 XENE
Xenon Pharmaceuticals Inc.
 227,330 $13,721,638
7 PTCT
Ptc Therapeutics, Inc.
 147,425 $12,025,457
8 INSM
INSMED Inc
 104,378 $11,128,782

All Filings in RXRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,529,909 416,869
2026-03-31 $259,586 84,556
2025-06-30 $108,137 21,371
2024-12-31 $368,494 54,511
2022-12-31 $626,082 81,204
2022-09-30 $1,244,997 117,011
2022-06-30 $1,401,667 172,195
2022-03-31 $650,128 90,800